The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Butterfly Medical, developer of a minimally invasive solution for benign prostatic hyperplasia (BPH), has earned EU MDR certification for its Butterfly prostatic retraction device. The regulatory ...
Butterfly Medical, developer of a proprietary minimally invasive solution for benign prostatic hyperplasia (BPH), today announced that it has received certification under the European Union Medical ...
BPH prostate treatment market is evolving toward a more patient-focused, technology-driven ecosystem. As innovation in both pharmaceuticals and minimally invasive procedures accelerates, companies ...
Introduction: Do not endure frequent urinationWaking up multiple times at night to use the toilet, weak urine flow, and the ...
Harnessing Real-World Data and AI to Advance Research and Treatment for Benign Prostatic Hyperplasia
Benign prostatic hyperplasia (BPH) is one of the most common urologic conditions affecting men as they age, with nearly 50% of men over 50 experiencing symptoms. Despite its prevalence, treatment ...
Teleflex Incorporated announced the presentation of multiple clinical studies at the 2025 American Urological Association Annual Meeting in Las Vegas, highlighting advancements in treatments for ...
Boost ROI by targeting minimally invasive BPH devices, outpatient care and Asia-Pacific expansion while investing in innovation, physician training and strategic partnerships.Dublin, Oct. 13, 2026 ...
TORONTO, June 10, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results